Antimicrobial susceptibility testing of Bordetella pertussis in Taiwan prompted by a case of pertussis in a paediatric patient

Journal of Medical Microbiology

Volumn 57, Issue 12, 2008, Pages 1577-1580

  Yao, Shu Man ^a   Liaw, Gwo Jen ^b   Chen, Ying Yan ^a   Yen, Meng Hsiu ^c   Chen, Ya Hui ^a   Mu, Jung Jung ^a   Chiang, Chuen Sheue ^a,d  

^a CENTER FOR DISEASE CONTROL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

^d NATIONAL TAIPEI UNIVERSITY OF NURSING AND HEALTH SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; AZITHROMYCIN; CEFOTAXIME; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GENTAMICIN;

ADD ON THERAPY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; CASE REPORT; CONTROLLED STUDY; DRUG TREATMENT FAILURE; HUMAN; INFANT; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PERTUSSIS; PNEUMONIA; PRIORITY JOURNAL; TAIWAN;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ERYTHROMYCIN; FEMALE; HUMANS; INFANT; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; MICROBIAL SENSITIVITY TESTS; TAIWAN; WHOOPING COUGH;

EID: 57749192477     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.2008/002857-0     Document Type: Article

References (16)

1. Bartkus, J. M., Juni, B. A., Ehresmann, K., Miller, C. A., Sanden, G. N., Cassiday, P. K., Saubolle, M., Lee, B., Long, J. & other authors (2003). Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol 41, 1167-1172.
2. Bass, J. W. (1986). Erythromycin for treatment and prevention of pertussis. Pediatr Infect Dis 5, 154-157.
3. Bonacorsi, S., Farnoux, C., Bidet, P., Caro, V., Aizenfisz, S., Benhayoun, M., Aujard, Y., Guiso, N. & Bingen, E. (2006). Treatment failure of nosocomial pertussis infection in a very-low-birth-weight neonate. J Clin Microbiol 44, 3830-3832.
4. Broder, K. R., Cortese, M. M., Iskander, J. K., Kretsinger, K., Slade, B. A., Brown, K. H., Mijalski, C. M., Tiwari, T., Weston, E. J. & other authors (2006). Preventing tetanus, diphtheria, and pertussis among adolescents: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccines. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 55, 1-34.
5. Celentano, L. P., Massari, M., Paramatti, D., Salmaso, S. & Tozzi, A. E. on behalf of the EUVAC-NET group (2005). Resurgence of pertussis in Europe. Pediatr Infect Dis J 24, 761-765.
6. CLSI (2006). Performance Standards for Antimicrobial Disk Susceptibility Test, 9th edn, approved standard M2-A9. Wayne, PA: Clinical and Laboratory Standards Institute.
7. Galanakis, E., Englund, J. A., Abe, P. & Qin, X. (2007). Antimicrobial susceptibility of Bordetella pertussis isolates in the state of Washington. Int J Antimicrob Agents 29, 609-611.
8. Gordon, K. A., Fusco, J., Biedenbach, D. J., Pfaller, M. A. & Jones, R. N. (2001). Antimicrobial susceptibility testing of clinical isolates of Bordetella pertussis from northern California: report from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother 45, 3599-3600.
9. Hill, B. C., Baker, C. N. & Tenover, F. C. (2000). A simplified method for testing Bordetella pertussis for resistance to erythromycin and other antimicrobial agents. J Clin Microbiol 38, 1151-1155.
10. Korgenski, E. K. & Daly, J. A. (1997). Surveillance and detection of erythromycin resistance in Bordetella pertussis isolates recovered from a pediatric population in the Intermountain West region of the United States. J Clin Microbiol 35, 2989-2991.
11. Langley, J. M., Halperin, S. A., Boucher, F. D., Smith, B. & the Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) (2004). Azithryomycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis. Pediatrics 114, e96-e101.
12. Lewis, K., Saubolle, M. A., Tenover, F. C., Rudinsky, M. F., Barbour, S. D. & Cherry, J. D. (1995). Pertussis caused by an erythromycin-resistant strain of Bordetella pertussis. Pediatr Infect Dis J 14, 388-391.
13. Lin, Y. C., Yao, S. M., Yan, J. J., Chen, Y. Y., Chiang, C. S., Wu, H. S. & Li, S. Y. (2007). Epidemiological shift in the prevalence of pertussis in Taiwan: implications for pertussis vaccination. J Med Microbiol 56, 533-537.
14. von König, C.-H. W. (2005). Use of antibiotics in the prevention and treatment of pertussis. Pediatr Infect Dis J 24, S66-S68.
15. Wilson, K. E., Cassiday, P. K., Popovic, T. & Sanden, G. N. (2002). Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. J Clin Microbiol 40, 2942-2944.
16. Yao, S. M., Lin, Y. C., Chou, C. Y., Chen, Y. Y., Hsiao, M. J., Chen, H. Y., Yan, J. J., Su, H. P. & Li, S. Y. (2005). Antigenic divergence of Bordetella pertussis isolates in Taiwan. J Clin Microbiol 43, 5457-5461.